Barclays PLC Buys 39,551 Shares of Diversified Healthcare Trust (NASDAQ:DHC)

Barclays PLC boosted its stake in Diversified Healthcare Trust (NASDAQ:DHC) by 12.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 364,065 shares of the real estate investment trust’s stock after acquiring an additional 39,551 shares during the period. Barclays PLC owned 0.15% of Diversified Healthcare Trust worth $838,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Invesco Ltd. raised its position in shares of Diversified Healthcare Trust by 5.0% in the 4th quarter. Invesco Ltd. now owns 772,528 shares of the real estate investment trust’s stock worth $1,777,000 after acquiring an additional 36,949 shares in the last quarter. Russell Investments Group Ltd. increased its holdings in Diversified Healthcare Trust by 43.7% in the fourth quarter. Russell Investments Group Ltd. now owns 306,211 shares of the real estate investment trust’s stock worth $704,000 after purchasing an additional 93,096 shares in the last quarter. Wells Fargo & Company MN increased its holdings in Diversified Healthcare Trust by 27.0% in the fourth quarter. Wells Fargo & Company MN now owns 139,393 shares of the real estate investment trust’s stock worth $321,000 after purchasing an additional 29,626 shares in the last quarter. Resona Asset Management Co. Ltd. acquired a new position in Diversified Healthcare Trust in the fourth quarter valued at approximately $183,000. Finally, RPO LLC bought a new position in shares of Diversified Healthcare Trust during the 4th quarter worth approximately $54,000. Institutional investors and hedge funds own 75.98% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently weighed in on DHC shares. B. Riley initiated coverage on shares of Diversified Healthcare Trust in a research note on Thursday, April 3rd. They issued a “buy” rating and a $4.50 price objective for the company. StockNews.com upgraded shares of Diversified Healthcare Trust from a “sell” rating to a “hold” rating in a research note on Thursday, April 10th.

Diversified Healthcare Trust Trading Up 31.0 %

Shares of Diversified Healthcare Trust stock opened at $2.86 on Wednesday. The stock has a market capitalization of $688.73 million, a P/E ratio of -1.77 and a beta of 2.37. Diversified Healthcare Trust has a 52-week low of $2.00 and a 52-week high of $4.24. The company has a debt-to-equity ratio of 1.44, a quick ratio of 11.57 and a current ratio of 11.57. The stock’s 50-day simple moving average is $2.40 and its 200 day simple moving average is $2.51.

Diversified Healthcare Trust (NASDAQ:DHC) last posted its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.02. Diversified Healthcare Trust had a negative net margin of 26.09% and a negative return on equity of 17.55%. The company had revenue of $386.86 million for the quarter, compared to analyst estimates of $381.19 million.

Diversified Healthcare Trust Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Tuesday, April 22nd will be given a $0.01 dividend. This represents a $0.04 annualized dividend and a dividend yield of 1.40%. The ex-dividend date is Tuesday, April 22nd. Diversified Healthcare Trust’s dividend payout ratio (DPR) is presently -2.60%.

About Diversified Healthcare Trust

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.